最新更新 :
28/04/2024
抗菌薬   Ofloxacin  
注射薬
溶媒内の安定性 混合時の安定性 安定性に影響する因子 互換性 投与経路 引用文献 PDF
   化学構造  

商品名   商品名     

商品名、賦形剤は国、製薬会社ごとに異なることがあります

Anzatax マレーシア
Floxil メキシコ
Floxitril インド
Floxstat エクアドル, コロンビア, メキシコ
Istaflox メキシコ
Menefloks トルコ
Oflocare ペルー
Oflocet チュニジア, ポルトガル, モロッコ
Oflogyl ベネズエラ
Ofloxacin アメリカ
Ofloxacine フランス
Ofloxin エジプト
Ofloxol マレーシア
Surnox スペイン
Tabrin ギリシア
Tarivid アイルランド, イギリス, オランダ, オーストリア, サウジアラビア, スイス, トルコ, ドイツ, ノルウェー, ハンガリー, ポルトガル, ポーランド, ルクセンブルグ
Zanocin インド, ポーランド
Zanovid インド
Zenflox インド
引用文献   注射薬   引用文献 : Ofloxacin  
形式 出版物
59 雑誌 Trissel LA, Gilbert DL, Martinez JF, Kim MC.
Compatibility of remifentanil hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2192-2196.
182 雑誌 Trissel LA, Gilbert DL, Martinez JF.
Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 56-60.
249 雑誌 Trissel LA, Martinez JF.
Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1996 ; 53: 1041-1045.
251 雑誌 Trissel LA, Gilbert DL, Martinez JF.
Compatibility of doxorubicin hydrochloride liposome injection with selected other drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 2708-2713.
299 雑誌 Trissel LA, Martinez JF, Gilbert DL.
Compatibility of cisatracurium besylate with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1735-1741.
300 雑誌 Trissel LA, Gilbert DL, Martinez JF.
Compatibility of propofol injectable emulsion with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1287-1292.
301 雑誌 Trissel LA, Gilbert DL, Martinez JF, Baker MB, Walter WV, Mirtallo JM.
Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1997 ; 54: 1295-1300.
444 雑誌 Bornstein M, Kao SH, Mercorelli M, Verma S.
Stability of an ofloxacin injection in various infusion fluids.
Am J Hosp Pharm 1992 ; 49: 2756-2760.
889 雑誌 Janknegt R, Stratermans T, Cilissen J, Lohman JJHM, Hooymans PM.
Ofloxacin intravenous. Compatibility with other antibacterial agents.
Pharm Weekbl [Sci] 1991 ; 13: 207-209.
921 雑誌 Trissel LA, Gilbert DL, Martinez JF.
Incompatibility and compatibility of amphotericin B cholesteryl sulfate complex with selected other drugs during simulated Y-site administration.
Hosp Pharm 1998 ; 33: 284-292.
1410 雑誌 Trissel LA, Martinez JF, Simmons M.
Compatibility of etoposide phosphate with selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 141-145.
1415 雑誌 Trissel L.A, Gilbert D.L, Martinez J.F, Baker M.B, Walter W.V, Mirtallo J.M.
Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
JPEN 1999 ; 23: 67-74.
1423 雑誌 Trissel LA, Martinez JF, Gilbert DL.
Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection.
J Am Pharm Assoc 1999 ; 39: 514-518.
1481 雑誌 Messerschmidt W.
Kompatibilität von ofloxacin mit ampicillin.
Krankenhauspharmazie 1994 ; 9: 337-340.
1625 雑誌 Trissel LA, Saenz C, Williams YW, Ingram D.
Incompatibilities of lansoprazole injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2001 ; 5: 314-321.
1668 雑誌 Zhang Y, Xu QA, Trissel LA, Williams KY.
Compatibility and stability of linezolid injection admixed with three quinolone antibiotics.
Ann Pharmacotherapy 2000 ; 34: 996-1001.
1712 雑誌 Trissel LA, Saenz CA.
Compatibility screening of Precedex during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 230-233.
1713 雑誌 Trissel LA, Saenz CA.
Compatibility screening of bivalirudin during simulated Y-site administration with other drugs.
Int J Pharm Compound 2002 ; 6: 311-315.
1721 雑誌 Trissel LA, Williams KY, Baker MB.
Compatibility screening of Hextend during simulated Y-site administration with other drugs.
Int J Pharm Compound 2001 ; 5: 69-72.
1754 雑誌 Trissel LA, Gilbert DL, Wolkin AC.
Compatibility of docetaxel with selected drugs during simulated Y-site administration.
Int J Pharm Compound 1999 ; 3: 241-244.
1925 雑誌 Trissel LA , Williams KY, Gilbert DL.
Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
J Am Pharm Assoc 2000 ; 40: 515-519.
2139 雑誌 Serrurier C, Chenot ED, Vigneron J, May I, Demor? B.
Assessment of injectable drug’s administration in two intensive care units and determination of potential physico-chemical incompatibilities.
EJHP Science 2006 ; 12,5: 96-99.
2155 雑誌 Battista C, Kane MP, Moon DG, Bailie GR.
Stability of ofloxacin in peritoneal dialysis solutions.
Perit Dial Int 1995 ; 15: 72-74.
3562 実験 Ofloxacin (Tarivid®) - Summary of Product Characteristics
Sanofi 2014
3791 ポスター Sadou Yaye H, Burtet E, Hamel C, Aljhni R, Gard C, Tilleul P.
Étude de la compatibilité physico-chimique du phloroglucinol injectable durant les mélanges au sein des tubulures en Y.
Apifh Congress, Paris November 2014 2014
3883 実験 Ceftazidime - Résumé des caractéristiques du produit
Arrow 2016

  Mentions Légales